Sign in
4/A

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046265

Options or other derivatives

  • Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Biller Scott Chief Scientific Officer 2018-05-07 Option exercise · Stock option (right to buy) −3,000 22,154 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…